Foresee Pharmaceuticals Co Ltd (6576) — Cash Flow Reinvestment Rate
Latest as of June 2022:
0.70x
Foresee Pharmaceuticals Co Ltd (6576) has a Cash Flow Reinvestment Rate of 0.70x as of June 2022, reinvesting NT$100.59 Million (capex NT$590.00K plus investments NT$100.00 Million) from operating cash flow of NT$143.03 Million. Check Foresee Pharmaceuticals Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.70x
(Capex + Investments) / Operating CF
Total Reinvested
NT$100.59 Million
Capex + Investments
Operating Cash Flow
NT$143.03 Million
TWD
Capital Expenditures
NT$590.00K
TWD
Annual Cash Flow Reinvestment Rate for Foresee Pharmaceuticals Co Ltd (None–None)
Year-by-year capital reinvestment analysis for Foresee Pharmaceuticals Co Ltd. For live market cap and broader valuation context, see Foresee Pharmaceuticals Co Ltd (6576) total market value.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow